- Home
- FFIC vs SEPN Comparison
FFIC vs SEPN Comparison
Compare FFIC & SEPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FFIC
- SEPN
- Stock Information
- Founded
- FFIC 1929
- SEPN 2022
- Country
- FFIC United States
- SEPN United States
- Employees
- FFIC N/A
- SEPN N/A
- Industry
- FFIC Major Banks
- SEPN
- Sector
- FFIC Finance
- SEPN
- Exchange
- FFIC Nasdaq
- SEPN NYSE
- Market Cap
- FFIC 415.1M
- SEPN 453.2M
- IPO Year
- FFIC 1995
- SEPN 2024
- Fundamental
- Price
- FFIC $12.25
- SEPN $10.62
- Analyst Decision
- FFIC Hold
- SEPN Strong Buy
- Analyst Count
- FFIC 3
- SEPN 5
- Target Price
- FFIC $16.17
- SEPN $26.75
- AVG Volume (30 Days)
- FFIC 231.1K
- SEPN 524.2K
- Earning Date
- FFIC 07-24-2025
- SEPN 08-15-2025
- Dividend Yield
- FFIC 7.41%
- SEPN N/A
- EPS Growth
- FFIC N/A
- SEPN N/A
- EPS
- FFIC N/A
- SEPN N/A
- Revenue
- FFIC $124,028,000.00
- SEPN $977,000.00
- Revenue This Year
- FFIC $112.30
- SEPN N/A
- Revenue Next Year
- FFIC $7.61
- SEPN $526.96
- P/E Ratio
- FFIC N/A
- SEPN N/A
- Revenue Growth
- FFIC N/A
- SEPN 108.76
- 52 Week Low
- FFIC $10.65
- SEPN $4.17
- 52 Week High
- FFIC $18.59
- SEPN $28.99
- Technical
- Relative Strength Index (RSI)
- FFIC 47.32
- SEPN N/A
- Support Level
- FFIC $11.30
- SEPN N/A
- Resistance Level
- FFIC $12.09
- SEPN N/A
- Average True Range (ATR)
- FFIC 0.30
- SEPN 0.00
- MACD
- FFIC 0.03
- SEPN 0.00
- Stochastic Oscillator
- FFIC 50.00
- SEPN 0.00
About FFIC Flushing Financial Corporation
Flushing Financial Corp operates as a bank holding company, which is engaged in the provision of banking and financial services. It provides Personal, Business, lending, Government banking, and Card services. Its principal business is attracting retail deposits from the general public and investing those deposits together with funds generated from ongoing operations and borrowings, in originations and purchases of multi-family residential properties, commercial business loans, commercial real estate mortgage loans, construction loans, small business administration loans, and other small business loans.
About SEPN SEPTERNA INC
Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, GLP-1R, GIPR, and GCGR.